Burnett Patrick 4
4 · Arcutis Biotherapeutics, Inc. · Filed Jan 7, 2026
Insider Transaction Report
Form 4
Burnett Patrick
See Remarks
Transactions
- Sale
Common Stock
2026-01-05$28.98/sh−2,490$72,166→ 94,120 total
Footnotes (2)
- [F1]The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on December 12, 2024, by the Reporting Person, with a plan end date of February 27, 2026.
- [F2]The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $28.77 to $29.19, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.